FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119473130> ?p ?o ?g. }

• W3119473130 abstract "ABSTRACT Purpose 50-60% of neuromuscular-disease patients remain undiagnosed even after extensive genetic testing that hinders precision-medicine/clinical-trial-enrollment. Importantly, those with DNA-based molecular diagnosis often remain without known molecular mechanism driving different degrees of disease severity that hinders patient stratification and trial-readiness. These are due to: a) clinical-genetic-heterogeneity (eg: limb-girdle-muscular-dystrophies(LGMDs)>30-subtypes); b) high-prevalence of variants-of-uncertain-significance (VUSs); (c) unresolved genotype-phenotype-correlations for patient stratification, and (d) lack of minimally-invasive biomarker-driven-assays. We therefore implemented a combinatorial phenotype-driven blood-biomarker functional-genomics approach to enhance diagnostics and trial-readiness by elucidating disease mechanisms of a neuromuscular-disease patient-cohort clinically-suspected of Dysferlinopathy/related-LGMD, the second-most-prevalent LGMD in the US. Methods We used CD14+monocyte protein-expression-assay on 364 Dysferlinopathy/related-LGMD-suspected patient-cohort without complete molecular-diagnosis or genotype-phenotype correlation; and then combined with blood-based targeted-transcriptome-sequencing (RNA-Seq) with tiered-analytical-algorithm correlating with clinical-measurements for a subset of patients. Results Our combinatorial-approach significantly increased the diagnostic-yield from 25% (N=326; 18%-27%; 95%CI) to 82% (N=38; 69.08% to 84.92%; 95% CI) by combining monocyte-assay with enhanced-RNA-Seq-analysis and clinical-correlation, following ACMG-AMP-guidelines. The tiered-analytical-approach detected aberrant-splicing, allele-expression-imbalance, nonsense-mediated-decay, and compound-heterozygosity without parental/offspring-DNA-testing, leading to VUS-reclassifications, identification of variant-pathomechanisms, and enhanced genotype-phenotype resolution including those with carrier-range Dysferlin-protein-expression and milder-symptoms, allowing patient-stratification for better trial-readiness. We identified uniform-distribution of pathogenic-variants across DYSF -gene-domains without any hotspot suggesting the relevance of upcoming gene-(full- DYSF -cDNA)-therapy trials. Conclusion Our results show the relevance of using a clinically-driven multi-tiered-approach utilizing a minimally-invasive biomarker-functional-genomic platform for precision-medicine-diagnostics, trial-recruitment/monitoring, elucidating pathogenic-mechanisms for patient stratification to enhance better trial outcomes, which in turn, will guide more rational use of current-therapeutics and development of novel-interventions for neuromuscular-disorders, and applicable to other genetic-disorders." @default.
• W3119473130 created "2021-01-18" @default.
• W3119473130 creator A5008716896 @default.
• W3119473130 creator A5029677222 @default.
• W3119473130 creator A5035214242 @default.
• W3119473130 creator A5041071963 @default.
• W3119473130 creator A5053390029 @default.
• W3119473130 creator A5057985163 @default.
• W3119473130 creator A5059749945 @default.
• W3119473130 creator A5074017468 @default.
• W3119473130 creator A5091205796 @default.
• W3119473130 date "2021-01-15" @default.
• W3119473130 modified "2023-10-14" @default.
• W3119473130 title "Combinatorial clinically driven blood biomarker functional genomics significantly enhances genotype-phenotype resolution and diagnostics in neuromuscular disease" @default.
• W3119473130 cites W1519867923 @default.
• W3119473130 cites W1872500596 @default.
• W3119473130 cites W1964178552 @default.
• W3119473130 cites W1983685203 @default.
• W3119473130 cites W1991817429 @default.
• W3119473130 cites W1993325764 @default.
• W3119473130 cites W2016276708 @default.
• W3119473130 cites W2036657040 @default.
• W3119473130 cites W2039847498 @default.
• W3119473130 cites W2050873030 @default.
• W3119473130 cites W2051978340 @default.
• W3119473130 cites W2059851290 @default.
• W3119473130 cites W2086666454 @default.
• W3119473130 cites W2109931578 @default.
• W3119473130 cites W2114534925 @default.
• W3119473130 cites W2128699738 @default.
• W3119473130 cites W2165608865 @default.
• W3119473130 cites W2227055473 @default.
• W3119473130 cites W2243857403 @default.
• W3119473130 cites W2482267567 @default.
• W3119473130 cites W2518121515 @default.
• W3119473130 cites W2519086121 @default.
• W3119473130 cites W2734607781 @default.
• W3119473130 cites W2753365382 @default.
• W3119473130 cites W2774024419 @default.
• W3119473130 cites W2798234260 @default.
• W3119473130 cites W2888844281 @default.
• W3119473130 cites W2889109244 @default.
• W3119473130 cites W2889644405 @default.
• W3119473130 cites W2898055118 @default.
• W3119473130 cites W2902198013 @default.
• W3119473130 cites W2909848920 @default.
• W3119473130 cites W2918300789 @default.
• W3119473130 cites W2937120929 @default.
• W3119473130 cites W2948477377 @default.
• W3119473130 cites W2950545834 @default.
• W3119473130 cites W2979935292 @default.
• W3119473130 cites W4233918295 @default.
• W3119473130 doi "https://doi.org/10.1101/2021.01.14.21249850" @default.
• W3119473130 hasPublicationYear "2021" @default.
• W3119473130 type Work @default.
• W3119473130 sameAs 3119473130 @default.
• W3119473130 citedByCount "1" @default.
• W3119473130 countsByYear W31194731302022 @default.
• W3119473130 crossrefType "posted-content" @default.
• W3119473130 hasAuthorship W3119473130A5008716896 @default.
• W3119473130 hasAuthorship W3119473130A5029677222 @default.
• W3119473130 hasAuthorship W3119473130A5035214242 @default.
• W3119473130 hasAuthorship W3119473130A5041071963 @default.
• W3119473130 hasAuthorship W3119473130A5053390029 @default.
• W3119473130 hasAuthorship W3119473130A5057985163 @default.
• W3119473130 hasAuthorship W3119473130A5059749945 @default.
• W3119473130 hasAuthorship W3119473130A5074017468 @default.
• W3119473130 hasAuthorship W3119473130A5091205796 @default.
• W3119473130 hasBestOaLocation W31194731301 @default.
• W3119473130 hasConcept C104317684 @default.
• W3119473130 hasConcept C10590036 @default.
• W3119473130 hasConcept C12125453 @default.
• W3119473130 hasConcept C126322002 @default.
• W3119473130 hasConcept C127716648 @default.
• W3119473130 hasConcept C135763542 @default.
• W3119473130 hasConcept C163763905 @default.
• W3119473130 hasConcept C16671776 @default.
• W3119473130 hasConcept C179786068 @default.
• W3119473130 hasConcept C2779134260 @default.
• W3119473130 hasConcept C2780673598 @default.
• W3119473130 hasConcept C2781197716 @default.
• W3119473130 hasConcept C54355233 @default.
• W3119473130 hasConcept C60644358 @default.
• W3119473130 hasConcept C70721500 @default.
• W3119473130 hasConcept C71924100 @default.
• W3119473130 hasConcept C86803240 @default.
• W3119473130 hasConceptScore W3119473130C104317684 @default.
• W3119473130 hasConceptScore W3119473130C10590036 @default.
• W3119473130 hasConceptScore W3119473130C12125453 @default.
• W3119473130 hasConceptScore W3119473130C126322002 @default.
• W3119473130 hasConceptScore W3119473130C127716648 @default.
• W3119473130 hasConceptScore W3119473130C135763542 @default.
• W3119473130 hasConceptScore W3119473130C163763905 @default.
• W3119473130 hasConceptScore W3119473130C16671776 @default.
• W3119473130 hasConceptScore W3119473130C179786068 @default.
• W3119473130 hasConceptScore W3119473130C2779134260 @default.
• W3119473130 hasConceptScore W3119473130C2780673598 @default.
• W3119473130 hasConceptScore W3119473130C2781197716 @default.
• W3119473130 hasConceptScore W3119473130C54355233 @default.
• W3119473130 hasConceptScore W3119473130C60644358 @default.

• next